Does CABOZANTINIB S-MALATE Cause Hepatotoxicity? 91 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 91 reports of Hepatotoxicity have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.2% of all adverse event reports for CABOZANTINIB S-MALATE.
91
Reports of Hepatotoxicity with CABOZANTINIB S-MALATE
0.2%
of all CABOZANTINIB S-MALATE reports
3
Deaths
19
Hospitalizations
How Dangerous Is Hepatotoxicity From CABOZANTINIB S-MALATE?
Of the 91 reports, 3 (3.3%) resulted in death, 19 (20.9%) required hospitalization, and 2 (2.2%) were considered life-threatening.
Is Hepatotoxicity Listed in the Official Label?
Yes, Hepatotoxicity is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Hepatotoxicity?
METHOTREXATE (1,917)
ACETAMINOPHEN (1,557)
LEFLUNOMIDE (829)
HYDROXYCHLOROQUINE (715)
PREDNISONE (707)
RITUXIMAB (702)
ETANERCEPT (699)
ADALIMUMAB (674)
CYCLOPHOSPHAMIDE (632)
SULFASALAZINE (613)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Hepatotoxicity Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE